| Filed On | Filing |
|---|---|
| 21 Oct 2026 | Form 3: Monteil Clement, Chief Scientific Officer |
| 31 Mar 2026 | Form 3: Haight Nelson M, Director |
| 20 Mar 2026 | Form 3: McCracken Nigel William, Director |
| 18 Mar 2026 |
Form 3: Foster James Alexander Cunliffe, Chief Executive Officer
Holds 287,987 shares of Ordinary Shares |
| 18 Mar 2026 | Form 3: Norton Evan Michael, Director |
| 18 Mar 2026 |
Form 3: Davis Jason, Chief Financial Officer
No securities owned |
| 18 Mar 2026 |
Form 3: Miller Iain David, Director
No securities owned |
Loading...
